Evolent (EVH)
Runs risk-based and fee-based specialty-care programs covering oncology, cardiology, and musculoskeletal conditions for health plans.
$3.78
After-hours close−0.01 (−0.26%)
At close$3.79(+2.71%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 511 | 556 | 640 | 647 | 621 | 647 | 484 | 444 | 480 | 469 | 496 | 653 |
| Cost of revenue | 387 | 454 | 536 | 540 | 541 | 571 | 381 | 367 | 404 | 417 | 434 | 572 |
| Gross profit | 124 | 102 | 104 | 107 | 81 | 76 | 102 | 77 | 76 | 52 | 62 | 81 |
| 142 | 123 | 118 | 99 | 97 | 94 | 104 | 74 | 75 | 62 | 72 | 90 | |
| Research & development | 7 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 97 | 81 | 79 | 69 | 67 | 47 | 78 | 74 | 75 | 62 | 72 | 69 | |
| General & administrative | 0 | 0 | 79 | 0 | 0 | 0 | 78 | 0 | 0 | 0 | 0 | 69 |
| Other expenses | 39 | 35 | 38 | 30 | 30 | 47 | 26 | 0 | 0 | 0 | 0 | 22 |
| Operating income | −18 | −21 | −13 | 8 | −16 | −19 | −2 | 3 | 1 | −10 | −10 | −10 |
| −13 | −27 | −3 | −6 | −7 | −5 | −62 | −24 | −21 | −421 | −16 | −16 | |
| Interest income | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest expense | 15 | 12 | 6 | 6 | 6 | 7 | 10 | 12 | 16 | 19 | 17 | 17 |
| Other non-operating income | −2 | 14 | −3 | 1 | 1 | −1 | 51 | 12 | 4 | 402 | −1 | −1 |
| Income before tax | −31 | −48 | −17 | 1 | −24 | −24 | −63 | −21 | −20 | −431 | −26 | −26 |
| Income tax expense | −6 | −15 | 1 | 0 | −1 | −1 | 1 | −1 | 1 | −2 | 1 | 3 |
| Net income from continuing operations | −25 | −33 | −17 | 2 | −23 | −23 | −65 | −20 | −21 | −429 | −27 | −28 |
| Net income | −25 | −33 | −17 | 2 | −23 | −23 | −65 | −20 | −21 | −429 | −27 | −28 |
| EPS, basic | −$0.30 | −$0.36 | −$0.22 | −$0.06 | −$0.27 | −$0.27 | −$0.63 | −$0.44 | −$0.24 | −$3.76 | −$0.24 | −$0.25 |
| EPS, diluted | −$0.30 | −$0.36 | −$0.22 | −$0.06 | −$0.27 | −$0.27 | −$0.63 | −$0.44 | −$0.24 | −$3.76 | −$0.24 | −$0.25 |
| Weighted average shares, basic | 112 | 114 | 114 | 115 | 115 | 115 | 115 | 116 | 114 | 114 | 112 | 113 |
| Weighted average shares, diluted | 112 | 114 | 114 | 115 | 115 | 115 | 115 | 116 | 114 | 114 | 112 | 113 |
| EBITDA | 18 | −6 | 19 | 36 | 12 | 13 | −29 | 15 | 23 | −367 | 14 | 13 |
| Depreciation & amortization | 35 | 30 | 30 | 30 | 30 | 30 | 24 | 24 | 27 | 45 | 22 | 22 |
| EBIT | −16 | −36 | −11 | 6 | −18 | −17 | −53 | −9 | −3 | −412 | −9 | −9 |
